Lin Yang, Liu Yi, Feng Jianfei, Ye Fuyong, Hu Lian, Cao Yong
Department of Cardiovascular Surgery of the GaoZhou People's Hospital, Gaozhou, Guangdong, China.
Ann Med Surg (Lond). 2025 Jan 31;87(2):497-505. doi: 10.1097/MS9.0000000000002885. eCollection 2025 Feb.
Thoracic aortic aneurysm/dissection (TAA/D) is a complicated vascular disorder with galloping development and high mortality. Phenotype switching plays an important role in the pathological process of TAA/D. Previous studies indicated the potential correlation between the expression level of lncRNA RP11-465L10.10 and MMP9 involved in the development of TAA/D. Here, our results showed that RP11-465L10.10 and MMP9 were highly increased in TAD patient tissues, which was consistent in Ang II-induced vascular smooth muscle cell (VSMC) phenotype switching. However, the effects and underlying mechanism of RP11-465L10.10 on VSMC phenotypic switching remain uncertain. Therefore, the expression of SM22α, cell proliferation, and migration were investigated when ectopically expressed RP11-465L10.10 in VSMCs. The results showed that RP11-465L10.10 overexpression decreased SM22α expression and facilitated VSMC proliferation, migration, and MMP9 expression. Furthermore, the NF-κB signaling pathway was enriched in transcriptome data analysis, indicating that NF-κB signaling may be involved in RP11-465L10.10-induced VSMC phenotype switching and MMP9 expression. In conclusion, this study demonstrated that RP11-465L10.10 induces VSMC phenotype switching and MMP9 expression via the NF-κB signaling pathway, suggesting that RP11-465L10.10 might be a potential therapeutic target for TAA/D treatment.
胸主动脉瘤/夹层(TAA/D)是一种发展迅速且死亡率高的复杂血管疾病。表型转换在TAA/D的病理过程中起重要作用。先前的研究表明lncRNA RP11-465L10.10的表达水平与参与TAA/D发展的MMP9之间存在潜在关联。在此,我们的结果显示,RP11-465L10.10和MMP9在TAD患者组织中高度升高,这在血管紧张素II诱导的血管平滑肌细胞(VSMC)表型转换中是一致的。然而,RP11-465L10.10对VSMC表型转换的影响及潜在机制仍不确定。因此,当在VSMC中异位表达RP11-465L10.10时,研究了平滑肌22α(SM22α)的表达、细胞增殖和迁移情况。结果显示,RP11-465L10.10过表达降低了SM22α的表达,并促进了VSMC的增殖、迁移和MMP9的表达。此外,在转录组数据分析中富集了核因子κB(NF-κB)信号通路,表明NF-κB信号通路可能参与了RP11-465L10.10诱导的VSMC表型转换和MMP9表达。总之,本研究表明RP11-465L10.10通过NF-κB信号通路诱导VSMC表型转换和MMP9表达,提示RP11-465L10.10可能是TAA/D治疗的潜在靶点。